Avanzanite
Amsterdam, NL · 1 known investors
Find your way into Avanzanite
Sign up to see every warm intro you have to Avanzanite
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avanzanite team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avanzanite is a biopharmaceutical commercialization and distribution company that partners with emerging research-based drug originators to license and distribute approved orphan (rare disease) medicines across European markets. It operates as an authorized wholesaler within the European Economic Area, aiming to expand patient access to rare disease treatments across 30+ European countries.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2025 · 3 sources
MVM Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avanzanite do?
- Avanzanite is a biopharmaceutical commercialization and distribution company that partners with emerging research-based drug originators to license and distribute approved orphan (rare disease) medicines across European markets. It operates as an authorized wholesaler within the European Economic Area, aiming to expand patient access to rare disease treatments across 30+ European countries.
- Who founded Avanzanite?
- Avanzanite was founded by Adam Plich, Anant Murthy.
- Who are Avanzanite's investors?
- Avanzanite's investors include MVM Life Science Partners.
- Where is Avanzanite headquartered?
- Avanzanite is headquartered in Amsterdam, NL.

